August 6th 2024
A panel of experts offer future perspectives in HR+ breast cancer.
A panel of experts offer perspectives in sequencing ADC-Based therapies in HR+ breast cancer.
July 29th 2024
A panel of experts discuss ADC-based treatment strategies in HR+ Breast cancer.
A panel of experts discuss treatment advancements targeting the PI3K/AKT pathway in HR+ Breast Cancer.
A panel of experts discuss navigating 2L treatment strategies.
A panel of experts offer perspectives in navigating treatment strategies with CDK4/6 inhibitors.
July 8th 2024
A panel of experts discuss treatment updates in regards to CDK4/6 inhibitors.
A panel of experts discuss the potential of individual tumor sequencing with bespoke testing methodologies.
July 1st 2024
A panel of experts give perspectives on optimizing biomarker testing in Advanced HR+/HER2- Breast Cancer.
A panel of experts discuss advancements in adjuvant therapy for early-stage breast cancer.
June 25th 2024
Expert breast oncologists examine adjuvant therapy approaches for early-stage hormone receptor-positive breast cancer, emphasizing the distinct treatment strategies and outcomes observed in pre- and post-menopausal patient populations.
Leading oncologists explore optimal biomarker testing strategies for early-stage breast cancer, examining the comparative advantages of tissue and liquid biopsies to guide personalized treatment decisions.
April 11th 2024
Drs Graff, Mahtani, McCann, and Rugo share moments that sparked their interest in oncology and setbacks they overcame when building their careers.